サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562242

北米の近視治療：2030年市場予測- 地域別分析- タイプ別、治療法別、年齢層別、エンドユーザー別

North America Myopia Treatment Market Forecast to 2030 - Regional Analysis - by Type, Treatment, Age Group, and End User

出版日
ページ情報
英文 109 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
北米の近視治療：2030年市場予測- 地域別分析- タイプ別、治療法別、年齢層別、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 109 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の近視治療市場は、2022年に39億3,890万米ドルと評価され、2030年には73億3,526万米ドルに達すると予測され、2022年から2030年までのCAGRは8.1%と推定されます。

近視有病率の上昇が北米の近視治療市場を後押し

近視の有病率が世界的に上昇していることは、公衆衛生上の重大な問題であり、特に子供と若年成人の間で増加しています。最近の研究では、2050年までに世界人口の50%近く、つまり50億人が近視になり、現在の平均30%から増加すると推定されています。米国でも近視の頻度は増加しており、その割合は42％と報告されており、わずか30年でほぼ倍増しています。この動向には、ライフスタイルの変化、都市化の進展、デジタル機器の長時間使用や屋外での露出の制限など、近業での広範な活動など、複数の要因が関与しています。遺伝的素因も一役買っていますが、環境要因も近視率を大幅に上昇させています。このようなライフスタイルと環境要因の影響により、遺伝的感受性と環境的影響との間の複雑な相互作用についての理解が深まり、この急成長している公衆衛生問題に対処するための包括的戦略の必要性がさらに強調されています。近視の有病率が上昇を続ける中、高度近視とそれに関連する眼合併症の長期的な影響を軽減するための積極的な介入、公衆衛生キャンペーン、革新的な治療アプローチの開発が重視されるようになっており、この多面的な世界的健康課題への取り組みの重要性が強調されています。

北米の近視治療市場概要

北米の近視治療市場は、米国、カナダ、メキシコに区分されます。米国は北米の近視治療市場で最大のシェアを占めています。米国の市場成長は、近視に関連した視力低下の増加や、未治療の近視による遠方視力障害の発生率の上昇などの要因によるものです。さらに、目の健康に対する政府の支援の高まりと技術の進歩は、北米市場の成長を促進する顕著な要因です。

米国の近視治療市場は、今後数年間で大きな成長が見込まれます。近視の有病率は近年増加しており、これが効果的な治療に対する需要を促進しています。2023年にMyopia Instituteが発表したデータによると、米国の有病率は42%と報告されており、わずか30年でほぼ倍増しています。さらに、近視に対する意識の高まりも市場成長の原動力となっています。例えば、Brien Holden Vision Instituteが主催する2024年近視啓発週間は、Review of Myopia Managementを公式共同スポンサーに選びました。この協力は、2024年5月13日から19日にかけて国内外で開催される近視啓発週間のリーチ拡大を支援します。近視は、白内障や緑内障といった他の眼疾患の発症リスクを高めるなど、近視に伴うリスクを認識する人が増えています。このため、近視を予防したり進行を遅らせたりする効果的な治療に対する需要が高まっています。米国における近視治療市場の成長を促すもう一つの要因は、高度な技術や治療が利用できるようになったことです。現在、矯正レンズ、オルソケラトロジー、薬理学的治療など、さまざまな近視治療が行われています。これらの治療はますます洗練され、効果的になっており、近視治療の需要を後押ししています。最後に、小児の近視有病率の増加も米国における近視治療市場の成長を後押ししています。近視と診断される子供が増えるにつれ、近視の予防や進行を遅らせる効果的な治療に対するニーズが高まっています。このため、小児用に特化した新しい治療法の研究開発への投資が増加しています。全体として、米国の近視治療市場は、近視の症状を認識する人が増え、効果的な治療に対する需要が高まるにつれて、今後数年間で成長すると予想されます。

北米の近視治療市場の収益と2030年までの予測（金額）

北米の近視治療市場のセグメンテーション

北米の近視治療市場は、タイプ、治療法、年齢層、エンドユーザー、国に分類されます。

タイプ別では、北米の近視治療市場は強度近視、変性近視、進行性近視に区分されます。2022年の北米の近視治療市場シェアは、強度近視分野が最大でした。

治療に関しては、北米の近視治療市場は低用量アトロピン点眼薬、コンタクトレンズ、オルソケラトロジー、屈折矯正手術に区分されます。2022年の北米の近視治療市場シェアは、低用量アトロピン点眼薬セグメントが最大でした。さらに、屈折矯正手術セグメントはレーシックとPRKに細分化されます。

年齢層別では、北米の近視治療市場は成人近視と小児近視に二分されます。2022年の北米の近視治療市場シェアは、成人近視部門が大きいです。

エンドユーザーに基づき、北米の近視治療市場は病院・クリニック、専門クリニック、屈折矯正手術センターに分類されます。2022年の北米の近視治療市場シェアは、病院・クリニックセグメントが最大でした。

国別では、北米の近視治療市場は米国、カナダ、メキシコに分類されます。米国が2022年の北米の近視治療市場シェアを独占しました。

Bausch Health Companies Inc、Alcon AG、CooperVision Inc、Johnson &Johnson Vision Care Inc、Topcon Healthcare Solutions Inc、Ziemer Ophthalmic Systems AG、Nidek Co Ltd、Eyes Vision SL、Haag-Streit AG、Carl Zeiss AG.は北米の近視治療市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の近視治療市場情勢

  • PEST分析
  • 企業シェア分析

第5章 北米の近視治療市場：主要市場力学

  • 北米の近視治療市場- 主な市場力学
  • 市場促進要因
    • 近視の有病率の上昇
    • 近視治療に対する意識の高まり
  • 市場抑制要因
    • 熟練した専門家の不足
  • 市場機会
    • ターゲットとする近視を治療するための先端技術の利用可能性の増加
  • 今後の動向
    • 近視治療における人工知能の応用
  • 促進要因と抑制要因の影響

第6章 近視治療市場-北米市場分析

第7章 北米の近視治療市場分析：タイプ別

  • 強度近視
  • 変性近視
  • 進行性近視

第8章 北米の近視治療市場分析：治療法別

  • 低用量アトロピン点眼薬
  • 屈折矯正手術
  • コンタクトレンズ
  • オルソケラトロジー

第9章 北米の近視治療市場分析：年齢層別

  • 成人近視
  • 小児近視

第10章 北米の近視治療市場分析：エンドユーザー別

  • 病院・クリニック
  • 専門クリニック
  • 屈折矯正手術センター

第11章 北米の近視治療市場：国別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ

第12章 業界情勢

  • 近視治療市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略
    • 成長戦略

第13章 企業プロファイル

  • Bausch Health Companies Inc
  • Alcon AG
  • CooperVision Inc
  • Johnson & Johnson Vision Care Inc
  • Topcon Healthcare Solutions Inc
  • Ziemer Ophthalmic Systems AG
  • Nidek Co Ltd
  • Eyes Vision SL
  • Haag-Streit AG
  • Carl Zeiss AG

第14章 付録

図表

List Of Tables

  • Table 1. North America Myopia Treatment Market Segmentation
  • Table 2. Market Share (~) by Companies in the Global Myopia Treatment Market (%)
  • Table 3. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 4. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 5. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 6. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 7. North America: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Country
  • Table 8. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 9. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 10. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 11. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 12. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 13. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 14. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 15. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 16. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 17. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 18. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 19. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 20. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 21. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 22. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 23. Recent Organic Growth Strategies in Myopia Treatment Market
  • Table 24. Recent Inorganic Growth Strategies in the Myopia Treatment Market
  • Table 25. Glossary of Terms, Myopia Treatment Market

List Of Figures

  • Figure 1. North America Myopia Treatment Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Myopia Treatment Market Revenue (US$ Million), 2022-2030
  • Figure 5. North America Myopia Treatment Market Share (%) - by Type (2022 and 2030)
  • Figure 6. High Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Degenerative Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Progressive Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. North America Myopia Treatment Market Share (%) - by Treatment (2022 and 2030)
  • Figure 10. Low-Dose Atropine Eye Drops: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Refractive Surgery: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. LASIK: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. PRK: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Contact Lenses: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Ortho-K: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America Myopia Treatment Market Share (%) - by Age Group (2022 and 2030)
  • Figure 17. Adult Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Childhood Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. North America Myopia Treatment Market Share (%) - by End User (2022 and 2030)
  • Figure 20. Hospitals and Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Specialty Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Refractive Surgery Centers: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. North America: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: Myopia Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 25. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Growth Strategies in Myopia Treatment Market
目次
Product Code: BMIRE00030510

The North America myopia treatment market was valued at US$ 3,938.90 million in 2022 and is expected to reach US$ 7,335.26 million by 2030; it is estimated to register a CAGR of 8.1% from 2022 to 2030.

Rising Prevalence of Myopia Fuels North America Myopia Treatment Market

The rising prevalence of myopia globally represents a significant public health concern, with increasing incidences observed among children and young adults, particularly. A recent study estimated that by 2050, nearly 50% of the world's population-or 5 billion people-will be myopic, up from the current average of 30%. The frequency of myopia is also increasing in the US; it has been reported to be 42%, nearly doubling in just three decades. Multiple factors contribute to this trend, including lifestyle changes, increased urbanization, and extensive near-work activities, such as prolonged use of digital devices and limited outdoor exposure. While genetic predisposition plays a role, environmental factors also contribute to escalating the rates of myopia substantially. The impact of these lifestyle and environmental factors has led to an enhanced understanding of the complex interplay between genetic susceptibility and environmental influences, further underscoring the need for comprehensive strategies to address this burgeoning public health issue. As the prevalence of myopia continues to rise, there is a growing emphasis on developing proactive interventions, public health campaigns, and innovative treatment approaches to mitigate the long-term implications of high myopia and its associated ocular complications, thereby emphasizing the importance of addressing this multifaceted global health challenge.

North America Myopia Treatment Market Overview

The North America myopia treatment market has been segmented into the US, Canada, and Mexico. The US holds the largest share of the North America myopia treatment market. The market growth in the US will be due to factors such as the growing myopia-related occurrences of vision loss and rising incidence of distant vision impairment from untreated myopia. Furthermore, the rising government support for eye health and technological advancements are prominent factors propelling the North America market growth.

The US myopia treatment market is expected to experience significant growth in the coming years. The prevalence of myopia has been increasing in recent years, which is driving the demand for effective treatments. The US has reported a prevalence of 42%, nearly doubling in just three decades, according to data released by the Myopia Institute in 2023. Furthermore, increasing awareness about myopia is also driving market growth. For instance, the Brien Holden Vision Institute's 2024 Myopia Awareness Week has selected Review of Myopia Management as its official co-sponsor. The collaboration will assist in expanding the reach of Myopia Awareness Week, which is scheduled for domestically and internationally, May 13-19, 2024. More people are becoming aware of the risks associated with myopia, such as an increased risk of developing other eye conditions-cataracts and glaucoma. This has led to a greater demand for effective treatments that can help prevent or slow down the progression of myopia. Another factor driving the growth of the myopia treatment market in the US is the availability of advanced technologies and treatments. Various treatments for myopia are now available, including corrective lenses, orthokeratology, and pharmacological treatments. These treatments are becoming increasingly sophisticated and effective, helping drive demand for myopia treatment. Finally, the growing prevalence of myopia among children is also driving the growth of the myopia treatment market in the US. As more children are diagnosed with myopia, there is a greater need for effective treatments that can help prevent or slow down its progression. This has led to increased investment in research and development of new treatments specifically designed for children. Overall, the US myopia treatment market is expected to grow in the coming years as more people become aware of the condition and demand for effective treatments increases.

North America Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)

North America Myopia Treatment Market Segmentation

The North America myopia treatment market is categorized into type, treatment, age group, end user, and country.

Based on type, the North America myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest North America myopia treatment market share in 2022.

In terms of treatment, the North America myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest North America myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.

By age group, the North America myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger North America myopia treatment market share in 2022.

Based on end user, the North America myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest North America myopia treatment market share in 2022.

Based on country, the North America myopia treatment market is categorized into the US, Canada, and Mexico. The US dominated the North America myopia treatment market share in 2022.

Bausch Health Companies Inc, Alcon AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, Topcon Healthcare Solutions Inc, Ziemer Ophthalmic Systems AG, Nidek Co Ltd, Eyes Vision SL, Haag-Streit AG, and Carl Zeiss AG. are some of the leading companies operating in the North America myopia treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Myopia Treatment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Market Share Analysis, By Companies

5. North America Myopia Treatment Market - Key Market Dynamics

  • 5.1 North America Myopia Treatment Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Myopia
    • 5.2.2 Increased Awareness of Myopia Treatment
  • 5.3 Market Restraints
    • 5.3.1 Lack of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Rising Availability of Advanced Technologies for Treating the Targeted Myopia
  • 5.5 Future Trends
    • 5.5.1 Application of Artificial Intelligence in Myopia Treatment
  • 5.6 Impact of Drivers and Restraints:

6. Myopia Treatment Market - North America Market Analysis

7. North America Myopia Treatment Market Analysis - by Type

  • 7.1 High Myopia
    • 7.1.1 Overview
    • 7.1.2 High Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Degenerative Myopia
    • 7.2.1 Overview
    • 7.2.2 Degenerative Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Progressive Myopia
    • 7.3.1 Overview
    • 7.3.2 Progressive Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Myopia Treatment Market Analysis - by Treatment

  • 8.1 Low-Dose Atropine Eye Drops
    • 8.1.1 Overview
    • 8.1.2 Low-Dose Atropine Eye Drops: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Refractive Surgery
    • 8.2.1 Overview
    • 8.2.2 Refractive Surgery: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.2.3 LASIK
    • 8.2.4 PRK
  • 8.3 Contact Lenses
    • 8.3.1 Overview
    • 8.3.2 Contact Lenses: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Ortho-K
    • 8.4.1 Overview
    • 8.4.2 Ortho-K: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Myopia Treatment Market Analysis - by Age Group

  • 9.1 Adult Myopia
    • 9.1.1 Overview
    • 9.1.2 Adult Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Childhood Myopia
    • 9.2.1 Overview
    • 9.2.2 Childhood Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Myopia Treatment Market Analysis - by End User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Overview
    • 10.1.2 Hospitals and Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Specialty Clinics
    • 10.2.1 Overview
    • 10.2.2 Specialty Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Refractive Surgery Centers
    • 10.3.1 Overview
    • 10.3.2 Refractive Surgery Centers: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Myopia Treatment Market - Country Analysis

  • 11.1 North America
    • 11.1.1 North America Myopia Treatment Market
    • 11.1.2 North America: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
      • 11.1.2.1 North America: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
      • 11.1.2.2 US
      • 11.1.2.3 US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.2.3.1 US: Myopia Treatment Market Breakdown, by Type
        • 11.1.2.3.2 US: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.2.3.3 US: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.2.3.4 US: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.2.3.5 US: Myopia Treatment Market Breakdown, by End User
      • 11.1.2.4 Canada
      • 11.1.2.5 Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.2.5.1 Canada: Myopia Treatment Market Breakdown, by Type
        • 11.1.2.5.2 Canada: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.2.5.3 Canada: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.2.5.4 Canada: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.2.5.5 Canada: Myopia Treatment Market Breakdown, by End User
      • 11.1.2.6 Mexico
      • 11.1.2.7 Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.2.7.1 Mexico: Myopia Treatment Market Breakdown, by Type
        • 11.1.2.7.2 Mexico: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.2.7.3 Mexico: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.2.7.4 Mexico: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.2.7.5 Mexico: Myopia Treatment Market Breakdown, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Myopia Treatment Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Bausch Health Companies Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Alcon AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 CooperVision Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Johnson & Johnson Vision Care Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Topcon Healthcare Solutions Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Ziemer Ophthalmic Systems AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Nidek Co Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Eyes Vision SL
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Haag-Streit AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Carl Zeiss AG
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms